£109.07

About as cheap as it gets — within 5% of the all-time low it hit 2 months ago.

£109 today · all-time low £107 (Sep 2026) · usually £109

Springer Molecular Basis for Therapy of AIDS-Defining Cancers

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 62 days · 62 data points (no recent data)

Historical
Generating forecast…
£110.10 £107.14 £107.79 £108.43 £109.08 £109.72 £110.37 22 August 2026 06 September 2026 21 September 2026 06 October 2026 22 October 2026
View at Amazon ↗

Price data last checked 29 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 62 days • 3 price levels

Days at Price
Current Price
47 days 4 days · current 11 days 0 12 24 35 47 £108 £109 £110 Days at Price

Price Analysis

Most common price: £108 (47 days, 75.8%)

Price range: £108 - £110

Price levels: 3 different prices over 62 days

Description

Cancer incidences increase in people living with HIV/AIDS. Over 2 million people currently live with HIV/AIDS in the US. This number will increase as HAART prolongs the average lifespan and as (at least in some states) the number of new HIV infections increase again. As this population ages their incidence rates for cancer will increase, as well. Recently, new rational targets for cancer therapy have emerged. But their application to the care of HIV+ patients is slow, because of concerns about the weakened immune status of the patients, because of possible drug interactions with HAART and because some of the AIDS defining cancer are rare.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

HIV-associated Hematological Malignancies
86% match

HIV-associated Hematological Malignancies

Springer

£112.02 24 Oct 2026
Cancers in People with HIV and AIDS: Progress and Challenges
85% match

Cancers in People with HIV and AIDS: Progress and Challenges

Springer

£108.01 21 Oct 2026
Molecular Targeted Therapy of Lung Cancer
85% match

Molecular Targeted Therapy of Lung Cancer

Springer

£114.71 27 Oct 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
84% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.67 22 Oct 2026
HIV & HTLV-I Associated Malignancies: 104 (Cancer Treatment and Research, 104)
83% match

HIV & HTLV-I Associated Malignancies: 104 (Cancer Treatment and Research, 104)

Springer

£129.72 24 Oct 2026
Advances in Cancer Stem Cell Biology
83% match

Advances in Cancer Stem Cell Biology

Springer

£112.48 24 Oct 2026
Gene-Based Therapies for Cancer (Current Cancer Research)
83% match

Gene-Based Therapies for Cancer (Current Cancer Research)

Springer

£110.00 23 Oct 2026
Cancer Genetics and Therapeutics: Focus on Phytochemicals
83% match

Cancer Genetics and Therapeutics: Focus on Phytochemicals

Springer

£75.55 22 Oct 2026
AIDS in Africa
82% match

AIDS in Africa

Springer

£129.98 23 Oct 2026
Cancer and AIDS: Part IV: Future Perspectives
82% match

Cancer and AIDS: Part IV: Future Perspectives

Springer

£72.30 25 Oct 2026
Methodological Issues in AIDS Behavioral Research (Aids Prevention and Mental Health)
82% match

Methodological Issues in AIDS Behavioral Research (Aids Prevention and Mental Health)

Springer

£113.76 22 Oct 2026
Molecular Determinants of Radiation Response (Current Cancer Research)
82% match

Molecular Determinants of Radiation Response (Current Cancer Research)

Springer

£108.97 23 Oct 2026
Advances in Endophytic Research
82% match

Advances in Endophytic Research

Springer

£148.21 23 Oct 2026
Signaling Pathways and Molecular Mediators in Metastasis
82% match

Signaling Pathways and Molecular Mediators in Metastasis

Springer

£113.76 11 Nov 2026
Non-coding RNAs and Cancer
82% match

Non-coding RNAs and Cancer

Springer

£80.67 24 Oct 2026
Bioactive Essential Oils and Cancer
82% match

Bioactive Essential Oils and Cancer

Springer

£109.25 21 Oct 2026
Nutraceuticals and Cancer
82% match

Nutraceuticals and Cancer

Springer

£113.76 23 Oct 2026
DNA Methylation and Cancer Therapy (Medical Intelligence Unit)
82% match

DNA Methylation and Cancer Therapy (Medical Intelligence Unit)

Springer

£113.76 22 Oct 2026
Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)
81% match

Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)

Springer

£75.96 24 Oct 2026
Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)
81% match

Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)

Springer

£73.14 24 Oct 2026
Cancer Metastasis, Molecular and Cellular Mechanisms and Clinical Intervention: 1 (Cancer Metastasis - Biology and Treatment, 1)
81% match

Cancer Metastasis, Molecular and Cellular Mechanisms and Clinical Intervention: 1 (Cancer Metastasis - Biology and Treatment, 1)

Springer

£111.27 22 Oct 2026
Molecular Basis of Breast Cancer: Prevention and Treatment
81% match

Molecular Basis of Breast Cancer: Prevention and Treatment

Springer

£74.21 27 Oct 2026
Modern Molecular Biology:: Approaches for Unbiased Discovery in Cancer Research (Applied Bioinformatics and Biostatistics in Cancer Research)
81% match

Modern Molecular Biology:: Approaches for Unbiased Discovery in Cancer Research (Applied Bioinformatics and Biostatistics in Cancer Research)

Springer

£107.87 22 Oct 2026
Pharmaceutical Perspectives of Cancer Therapeutics
81% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£179.99 27 Oct 2026